3-benzyl-6-bromo-2-methoxyquinoline CAS NO.654655-69-3

Min.Order: 1 Kilogram
Payment Terms: L/C,T/T,

Product Details

Keywords

Bedaquiline intermediate
6-Bromo-2-methoxy-3-benzylquinoline
Bedaquiline Impurity A

Quick Details

ProName: 3-benzyl-6-bromo-2-methoxyquinoline
CasNo: 654655-69-3
Molecular Formula: C17H14BrNO
Appearance: White Powder
Application: 3-benzyl-6-bromo-2-methoxyquinoline is...
DeliveryTime: 7-15 working days
PackAge: net weight 25kg/drum
Port: Shanghai/ Guangzhou
ProductionCapacity: Metric Ton/Day
Purity: 99.0%min
Storage: Sealed in dry,Room Temperature
Transportation: by air/sea/express
LimitNum: 1 Kilogram

Superiority

Product description

Product Name:3-benzyl-6-bromo-2-methoxyquinoline/654655-69-3 / Bedaquiline intermediate

Product number:BJM-026 CAS:654655-69-3

Molecular formula:C17H14BrNO Molecular weight:328

Content:99.0%min Origin:China

Structure:

654655-69-3 / 3-benzyl-6-bromo-2-methoxyquinoline /Bedaquiline intremediate

Specification:

Items	Specification
Appearance	white powder
Identification	Conform with the standard
Loss on drying	1.0% max
Assay	99.0% min

Usage: Bedaquiline intermediate

Company information:

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016, obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd, and the new production base settled in Geputan chemical park with a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends